Figure 2 — Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer

Research Paper|Volume 8, Issue 12|pp. 3520–3534

Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer

Back to articleFigure 2(2 of 11)

100%

Figure 2.Growth inhibition of HUVEC and HepG2 cells at different concentration of doxorubicin. Data from 3 independent experiments are shown. *p < 0.05, n.s. not significant, vs 0.02μM.